Options Pro Says Intercept Shares Will Go 'Much Higher' Through The End Of The Year

Rachel Shasha was recently a guest on #PreMarket Prep, a daily trading idea radio show hosted by Joel Elconin and Dennis Dick.

Shasha, the founder of Sassy Options, discussed high priced stocks that have a lot of movement, specifically, Intercept Pharmaceuticals Inc (NASDAQ: ICPT). She said that she had already purchased January 2016 calls which have worked out "beautifully" thus far.

Shasha added that the investment idea is still a buy-idea despite some "healthy" consolidation seen in shares recently. She added that it is often difficult to invest in weekly, bi-weekly and monthly options given expected volatility but over a full year shares are expected to go "much higher."

She finally argued that Intercept is one of the only companies that hold the potential to produce meaningful therapies among patients suffering from liver issues, which represents a large market.

Check out the full interview below: